News Focus
News Focus
Followers 22
Posts 4699
Boards Moderated 0
Alias Born 01/27/2022

Re: rosemountbomber post# 433479

Monday, 03/03/2025 11:28:23 AM

Monday, March 03, 2025 11:28:23 AM

Post# of 448111

I still think this is a sad commentary on the medical community. Isn't it their jobs to treat patients. Has that responsibility morphed into awaiting marketing campaigns to guide their treatment protocols?



Look at the guidelines, and look at what is covered by insurance. We can't place all the blame on doctors. Spend some time reading opinions on Vascepa within the healthcare industry. Most of what I see is "well, it's really just fish oil...it's for high trigs...bad placebo...". Plus, when you've got statins, PCSK9, Ezetimibe, and BA, there is not really a "need" for another solution. Look at how EZE+BA combo pill is doing in the UK compared to Vazkepa.

Most docs have their "go-to" authorities in the industry. And if they follow someone like Nissen (and there are many others), then they will have a natural skepticism towards Vascepa and fish oil in general.

The fact is, Amarin stopped trying in the U.S. years ago. New Medications don't just "sell themselves". You think GLP-1's just "magically" fly off the shelves? No. Their companies SELL them. They MARKET them. You can't watch TV for 5 minutes without seeing a commercial for them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News